Levofloxacin/ketorolac combination versus levofloxacin alone for topically treating moderate-severe acute bacterial conjunctivitis: a randomized controlled trial.
Francesco Bandello, Oleg Ivanovich Ledbedev, Giovanni Alessio, Teresio Avitabile, Niccolò Castellino, Giuseppe Covello, Michele Figus, Aleksey Lisitsyn, Gregorio Lo Giudice, Alexander Malygin, Zoya Nagomova, Nicolò Nicolini, Antonino Pioppo, Pasquale Puzo, Dario Romano, Luca Rossetti, Andrey Evgenievich Yavorky, Giorgio Ciprandi, Aleksei Seleznev, Boris Malyugin
Graefes Arch Clin Exp Ophthalmol 10.1007/s00417-026-07311-3
摘要
摘要
BACKGROUND: This study aimed to obtain the first evidence-based microbiological confirmation of the efficacy and an assessment of the local tolerability of a combination of an ocular antibiotic and a non-steroidal anti-inflammatory drug in treating moderate-to-severe acute bacterial conjunctivitis (ABC). METHODS: This was a phase II, randomized, parallel-group, masked-assessor, multicentre study to assess the non-inferiority of levofloxacin plus ketorolac eye drops versus levofloxacin eye drops alone in microbiological eradication (protocol number: LEVOKETO_02-2020). Treatment lasted 5 days. Non-inferiority was demonstrated if the lower bound of the two-sided 95% confidence interval (CI) of the difference was > -0.15. The study randomized 252 patients enrolled in 20 centers (Italy and Russia). The primary endpoint was the proportion of patients with microbiological eradication of levofloxacin-susceptible bacteria. Secondary endpoints included microbiological and clinical outcomes. This study is registered with EudraCT number 2020-005263-31. RESULTS: At the final visit, 100% of patients in the test arm had eradicated levofloxacin-susceptible pathogens, versus 92.59% in the control arm (difference = 0.0741; 95% CI: 0.0042-0.1439). In the Per Protocol population, the levofloxacin-ketorolac eye drops combination proved to be superior (P < 0.0001) to levofloxacin eye drops alone in bacterial eradication during treatment of ABC with moderate-to-severe signs in adults despite being administered with a simplified dosing regimen. Local tolerability was similar between arms (p = 0.7666). CONCLUSIONS: The levofloxacin-ketorolac combination was effective in bacterial eradication and well-tolerated in adults with moderate-to-severe ABC. These results suggest a possible positive levofloxacin-ketorolac interaction warranting further investigation in a phase III study.
KM 提取结果
0 个 Figure · 0 个 KM 面板